There were 23 press releases posted in the last 24 hours and 166,036 in the last 365 days.

Global Lymphoma Therapeutics Industry

Lymphoma Therapeutics market worldwide is projected to grow by US$9. 3 Billion, driven by a compounded growth of 7. 7%. Hodgkin Lymphoma (HL), one of the segments analyzed and sized in this study, displays the potential to grow at over 7%.

/EIN News/ -- New York, Oct. 11, 2019 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Lymphoma Therapeutics Industry" - https://www.reportlinker.com/p05818005/?utm_source=GNW
The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$2.2 Billion by the year 2025, Hodgkin Lymphoma (HL) will bring in healthy gains adding significant momentum to global growth.

- Representing the developed world, the United States will maintain a 6.5% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$323.7 Million to the region’s size and clout in the next 5 to 6 years. Over US$278.5 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Hodgkin Lymphoma (HL) will reach a market size of US$139.3 Million by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 11.4% over the next couple of years and add approximately US$2.6 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

- Competitors identified in this market include among others, Celgene Corporation; F. Hoffmann-La Roche AG; Johnson & Johnson; Seattle Genetics, Inc.


Read the full report: https://www.reportlinker.com/p05818005/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Global Competitor Market Shares
Lymphoma Therapeutics Competitor Market Share Scenario
Worldwide (in %): 2019 & 2028
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Table 1: Lymphoma Therapeutics Global Market Estimates and
Forecasts in US$ Million by Region/Country: 2018-2025
Table 2: Lymphoma Therapeutics Global Retrospective Market
Scenario in US$ Million by Region/Country: 2009-2017
Table 3: Lymphoma Therapeutics Market Share Shift across Key
Geographies Worldwide: 2009 VS 2019 VS 2025
Table 4: Hodgkin Lymphoma (HL) (Disease Type) World Market by
Region/Country in US$ Million: 2018 to 2025
Table 5: Hodgkin Lymphoma (HL) (Disease Type) Historic Market
Analysis by Region/Country in US$ Million: 2009 to 2017
Table 6: Hodgkin Lymphoma (HL) (Disease Type) Market Share
Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS
2025
Table 7: Non-Hodgkin Lymphoma (NHL) (Disease Type) Potential
Growth Markets Worldwide in US$ Million: 2018 to 2025
Table 8: Non-Hodgkin Lymphoma (NHL) (Disease Type) Historic
Market Perspective by Region/Country in US$ Million: 2009 to
2017
Table 9: Non-Hodgkin Lymphoma (NHL) (Disease Type) Market Sales
Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
US Lymphoma Therapeutics Market Share (in %) by Company: 2019 &
2025
Table 10: United States Lymphoma Therapeutics Market Estimates
and Projections in US$ Million by Disease Type: 2018 to 2025
Table 11: Lymphoma Therapeutics Market in the United States by
Disease Type: A Historic Review in US$ Million for 2009-2017
Table 12: United States Lymphoma Therapeutics Market Share
Breakdown by Disease Type: 2009 VS 2019 VS 2025
CANADA
Table 13: Canadian Lymphoma Therapeutics Market Estimates and
Forecasts in US$ Million by Disease Type: 2018 to 2025
Table 14: Canadian Lymphoma Therapeutics Historic Market Review
by Disease Type in US$ Million: 2009-2017
Table 15: Lymphoma Therapeutics Market in Canada: Percentage
Share Breakdown of Sales by Disease Type for 2009, 2019, and
2025
JAPAN
Table 16: Japanese Market for Lymphoma Therapeutics: Annual
Sales Estimates and Projections in US$ Million by Disease Type
for the Period 2018-2025
Table 17: Lymphoma Therapeutics Market in Japan: Historic Sales
Analysis in US$ Million by Disease Type for the Period
2009-2017
Table 18: Japanese Lymphoma Therapeutics Market Share Analysis
by Disease Type: 2009 VS 2019 VS 2025
CHINA
Table 19: Chinese Lymphoma Therapeutics Market Growth Prospects
in US$ Million by Disease Type for the Period 2018-2025
Table 20: Lymphoma Therapeutics Historic Market Analysis in
China in US$ Million by Disease Type: 2009-2017
Table 21: Chinese Lymphoma Therapeutics Market by Disease Type:
Percentage Breakdown of Sales for 2009, 2019, and 2025
EUROPE
Market Facts & Figures
European Lymphoma Therapeutics Market: Competitor Market Share
Scenario (in %) for 2019 & 2025
Table 22: European Lymphoma Therapeutics Market Demand Scenario
in US$ Million by Region/Country: 2018-2025
Table 23: Lymphoma Therapeutics Market in Europe: A Historic
Market Perspective in US$ Million by Region/Country for the
Period 2009-2017
Table 24: European Lymphoma Therapeutics Market Share Shift by
Region/Country: 2009 VS 2019 VS 2025
Table 25: European Lymphoma Therapeutics Market Estimates and
Forecasts in US$ Million by Disease Type: 2018-2025
Table 26: Lymphoma Therapeutics Market in Europe in US$ Million
by Disease Type: A Historic Review for the Period 2009-2017
Table 27: European Lymphoma Therapeutics Market Share Breakdown
by Disease Type: 2009 VS 2019 VS 2025
FRANCE
Table 28: Lymphoma Therapeutics Market in France by Disease
Type: Estimates and Projections in US$ Million for the Period
2018-2025
Table 29: French Lymphoma Therapeutics Historic Market Scenario
in US$ Million by Disease Type: 2009-2017
Table 30: French Lymphoma Therapeutics Market Share Analysis by
Disease Type: 2009 VS 2019 VS 2025
GERMANY
Table 31: Lymphoma Therapeutics Market in Germany: Recent Past,
Current and Future Analysis in US$ Million by Disease Type for
the Period 2018-2025
Table 32: German Lymphoma Therapeutics Historic Market Analysis
in US$ Million by Disease Type: 2009-2017
Table 33: German Lymphoma Therapeutics Market Share Breakdown
by Disease Type: 2009 VS 2019 VS 2025
ITALY
Table 34: Italian Lymphoma Therapeutics Market Growth Prospects
in US$ Million by Disease Type for the Period 2018-2025
Table 35: Lymphoma Therapeutics Historic Market Analysis in
Italy in US$ Million by Disease Type: 2009-2017
Table 36: Italian Lymphoma Therapeutics Market by Disease Type:
Percentage Breakdown of Sales for 2009, 2019, and 2025
UNITED KINGDOM
Table 37: United Kingdom Market for Lymphoma Therapeutics:
Annual Sales Estimates and Projections in US$ Million by
Disease Type for the Period 2018-2025
Table 38: Lymphoma Therapeutics Market in the United Kingdom:
Historic Sales Analysis in US$ Million by Disease Type for the
Period 2009-2017
Table 39: United Kingdom Lymphoma Therapeutics Market Share
Analysis by Disease Type: 2009 VS 2019 VS 2025
SPAIN
Table 40: Spanish Lymphoma Therapeutics Market Estimates and
Forecasts in US$ Million by Disease Type: 2018 to 2025
Table 41: Spanish Lymphoma Therapeutics Historic Market Review
by Disease Type in US$ Million: 2009-2017
Table 42: Lymphoma Therapeutics Market in Spain: Percentage
Share Breakdown of Sales by Disease Type for 2009, 2019, and
2025
RUSSIA
Table 43: Russian Lymphoma Therapeutics Market Estimates and
Projections in US$ Million by Disease Type: 2018 to 2025
Table 44: Lymphoma Therapeutics Market in Russia by Disease
Type: A Historic Review in US$ Million for 2009-2017
Table 45: Russian Lymphoma Therapeutics Market Share Breakdown
by Disease Type: 2009 VS 2019 VS 2025
REST OF EUROPE
Table 46: Rest of Europe Lymphoma Therapeutics Market Estimates
and Forecasts in US$ Million by Disease Type: 2018-2025
Table 47: Lymphoma Therapeutics Market in Rest of Europe in US$
Million by Disease Type: A Historic Review for the Period
2009-2017
Table 48: Rest of Europe Lymphoma Therapeutics Market Share
Breakdown by Disease Type: 2009 VS 2019 VS 2025
ASIA-PACIFIC
Table 49: Asia-Pacific Lymphoma Therapeutics Market Estimates
and Forecasts in US$ Million by Region/Country: 2018-2025
Table 50: Lymphoma Therapeutics Market in Asia-Pacific:
Historic Market Analysis in US$ Million by Region/Country for
the Period 2009-2017
Table 51: Asia-Pacific Lymphoma Therapeutics Market Share
Analysis by Region/Country: 2009 VS 2019 VS 2025
Table 52: Lymphoma Therapeutics Market in Asia-Pacific by
Disease Type: Estimates and Projections in US$ Million for the
Period 2018-2025
Table 53: Asia-Pacific Lymphoma Therapeutics Historic Market
Scenario in US$ Million by Disease Type: 2009-2017
Table 54: Asia-Pacific Lymphoma Therapeutics Market Share
Analysis by Disease Type: 2009 VS 2019 VS 2025
AUSTRALIA
Table 55: Lymphoma Therapeutics Market in Australia: Recent
Past, Current and Future Analysis in US$ Million by Disease
Type for the Period 2018-2025
Table 56: Australian Lymphoma Therapeutics Historic Market
Analysis in US$ Million by Disease Type: 2009-2017
Table 57: Australian Lymphoma Therapeutics Market Share
Breakdown by Disease Type: 2009 VS 2019 VS 2025
INDIA
Table 58: Indian Lymphoma Therapeutics Market Estimates and
Forecasts in US$ Million by Disease Type: 2018 to 2025
Table 59: Indian Lymphoma Therapeutics Historic Market Review
by Disease Type in US$ Million: 2009-2017
Table 60: Lymphoma Therapeutics Market in India: Percentage
Share Breakdown of Sales by Disease Type for 2009, 2019, and
2025
SOUTH KOREA
Table 61: Lymphoma Therapeutics Market in South Korea: Recent
Past, Current and Future Analysis in US$ Million by Disease
Type for the Period 2018-2025
Table 62: South Korean Lymphoma Therapeutics Historic Market
Analysis in US$ Million by Disease Type: 2009-2017
Table 63: Lymphoma Therapeutics Market Share Distribution in
South Korea by Disease Type: 2009 VS 2019 VS 2025
REST OF ASIA-PACIFIC
Table 64: Rest of Asia-Pacific Market for Lymphoma
Therapeutics: Annual Sales Estimates and Projections in US$
Million by Disease Type for the Period 2018-2025
Table 65: Lymphoma Therapeutics Market in Rest of Asia-Pacific:
Historic Sales Analysis in US$ Million by Disease Type for the
Period 2009-2017
Table 66: Rest of Asia-Pacific Lymphoma Therapeutics Market
Share Analysis by Disease Type: 2009 VS 2019 VS 2025
LATIN AMERICA
Table 67: Latin American Lymphoma Therapeutics Market Trends by
Region/Country in US$ Million: 2018-2025
Table 68: Lymphoma Therapeutics Market in Latin America in US$
Million by Region/Country: A Historic Perspective for the
Period 2009-2017
Table 69: Latin American Lymphoma Therapeutics Market
Percentage Breakdown of Sales by Region/Country: 2009, 2019,
and 2025
Table 70: Latin American Lymphoma Therapeutics Market Growth
Prospects in US$ Million by Disease Type for the Period
2018-2025
Table 71: Lymphoma Therapeutics Historic Market Analysis in
Latin America in US$ Million by Disease Type: 2009-2017
Table 72: Latin American Lymphoma Therapeutics Market by
Disease Type: Percentage Breakdown of Sales for 2009, 2019, and
2025
ARGENTINA
Table 73: Argentinean Lymphoma Therapeutics Market Estimates
and Forecasts in US$ Million by Disease Type: 2018-2025
Table 74: Lymphoma Therapeutics Market in Argentina in US$
Million by Disease Type: A Historic Review for the Period
2009-2017
Table 75: Argentinean Lymphoma Therapeutics Market Share
Breakdown by Disease Type: 2009 VS 2019 VS 2025
BRAZIL
Table 76: Lymphoma Therapeutics Market in Brazil by Disease
Type: Estimates and Projections in US$ Million for the Period
2018-2025
Table 77: Brazilian Lymphoma Therapeutics Historic Market
Scenario in US$ Million by Disease Type: 2009-2017
Table 78: Brazilian Lymphoma Therapeutics Market Share Analysis
by Disease Type: 2009 VS 2019 VS 2025
MEXICO
Table 79: Lymphoma Therapeutics Market in Mexico: Recent Past,
Current and Future Analysis in US$ Million by Disease Type for
the Period 2018-2025
Table 80: Mexican Lymphoma Therapeutics Historic Market
Analysis in US$ Million by Disease Type: 2009-2017
Table 81: Mexican Lymphoma Therapeutics Market Share Breakdown
by Disease Type: 2009 VS 2019 VS 2025
REST OF LATIN AMERICA
Table 82: Rest of Latin America Lymphoma Therapeutics Market
Estimates and Projections in US$ Million by Disease Type: 2018
to 2025
Table 83: Lymphoma Therapeutics Market in Rest of Latin America
by Disease Type: A Historic Review in US$ Million for 2009-2017
Table 84: Rest of Latin America Lymphoma Therapeutics Market
Share Breakdown by Disease Type: 2009 VS 2019 VS 2025
MIDDLE EAST
Table 85: The Middle East Lymphoma Therapeutics Market
Estimates and Forecasts in US$ Million by Region/Country:
2018-2025
Table 86: Lymphoma Therapeutics Market in the Middle East by
Region/Country in US$ Million: 2009-2017
Table 87: The Middle East Lymphoma Therapeutics Market Share
Breakdown by Region/Country: 2009, 2019, and 2025
Table 88: The Middle East Lymphoma Therapeutics Market
Estimates and Forecasts in US$ Million by Disease Type: 2018 to
2025
Table 89: The Middle East Lymphoma Therapeutics Historic Market
by Disease Type in US$ Million: 2009-2017
Table 90: Lymphoma Therapeutics Market in the Middle East:
Percentage Share Breakdown of Sales by Disease Type for 2009,
2019, and 2025
IRAN
Table 91: Iranian Market for Lymphoma Therapeutics: Annual
Sales Estimates and Projections in US$ Million by Disease Type
for the Period 2018-2025
Table 92: Lymphoma Therapeutics Market in Iran: Historic Sales
Analysis in US$ Million by Disease Type for the Period
2009-2017
Table 93: Iranian Lymphoma Therapeutics Market Share Analysis
by Disease Type: 2009 VS 2019 VS 2025
ISRAEL
Table 94: Israeli Lymphoma Therapeutics Market Estimates and
Forecasts in US$ Million by Disease Type: 2018-2025
Table 95: Lymphoma Therapeutics Market in Israel in US$ Million
by Disease Type: A Historic Review for the Period 2009-2017
Table 96: Israeli Lymphoma Therapeutics Market Share Breakdown
by Disease Type: 2009 VS 2019 VS 2025
SAUDI ARABIA
Table 97: Saudi Arabian Lymphoma Therapeutics Market Growth
Prospects in US$ Million by Disease Type for the Period
2018-2025
Table 98: Lymphoma Therapeutics Historic Market Analysis in
Saudi Arabia in US$ Million by Disease Type: 2009-2017
Table 99: Saudi Arabian Lymphoma Therapeutics Market by Disease
Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
UNITED ARAB EMIRATES
Table 100: Lymphoma Therapeutics Market in the United Arab
Emirates: Recent Past, Current and Future Analysis in US$
Million by Disease Type for the Period 2018-2025
Table 101: United Arab Emirates Lymphoma Therapeutics Historic
Market Analysis in US$ Million by Disease Type: 2009-2017
Table 102: Lymphoma Therapeutics Market Share Distribution in
United Arab Emirates by Disease Type: 2009 VS 2019 VS 2025
REST OF MIDDLE EAST
Table 103: Lymphoma Therapeutics Market in Rest of Middle East:
Recent Past, Current and Future Analysis in US$ Million by
Disease Type for the Period 2018-2025
Table 104: Rest of Middle East Lymphoma Therapeutics Historic
Market Analysis in US$ Million by Disease Type: 2009-2017
Table 105: Rest of Middle East Lymphoma Therapeutics Market
Share Breakdown by Disease Type: 2009 VS 2019 VS 2025
AFRICA
Table 106: African Lymphoma Therapeutics Market Estimates and
Projections in US$ Million by Disease Type: 2018 to 2025
Table 107: Lymphoma Therapeutics Market in Africa by Disease
Type: A Historic Review in US$ Million for 2009-2017
Table 108: African Lymphoma Therapeutics Market Share Breakdown
by Disease Type: 2009 VS 2019 VS 2025

IV. COMPETITION

AMGEN
CELGENE CORPORATION
F. HOFFMANN-LA ROCHE AG
JOHNSON & JOHNSON
SEATTLE GENETICS
ASTELLAS PHARMA, INC.
ASTRAZENECA PLC
BRISTOL-MYERS SQUIBB COMPANY
CHUGAI PHARMACEUTICAL
EISAI CO.
ELI LILLY AND COMPANY
FORMA THERAPEUTICS
GLAXOSMITHKLINE PLC
IMMUNOMEDICS
MERCK & CO., INC.
PFIZER, INC
SPECTRUM PHARMACEUTICALS
TRANSGENE SA

V. CURATED RESEARCH
Read the full report: https://www.reportlinker.com/p05818005/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001
Distribution channels: Media, Advertising & PR


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.